CDNA

CareDx, Inc | Cotação de Ações

Última atualização19/09/2025, 17:00:03

PreçoUS$ 14,59

Variação (dia)-US$ 0,18 (-1.22%)▼

Min. 52 SemanasUS$ 10,96

Máx. 52 SemanasUS$ 32,97

Capitalização de mercado--

Endereço: 8000 Marina Boulevard, South San Francisco, CA, 94005

Telefone: 415 287 2300

Funcionários: 644

CareDx, Inc.CDNA

US$ 14,59

- 0,181,2%

19/09/2025 17:00:03

1D 7D 1M 3M 1A Tudo

Visão geral da empresa

Preço atualUS$ 14,59

Valor de mercado--

AberturaUS$ 13,51

Preço máximoUS$ 14,95

Preço mínimoUS$ 14,57

VolumeUS$ 2,3 mi

Fechamento anteriorUS$ 14,77

CareDx, Inc. engages in the discovery, development, and commercialization of diagnostic solutions for transplant patients and caregivers in the United States and internationally. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. The company offers Olerup SSP, which is used to type human leukocyte antigen (HLA) alleles based on sequence specific primer technology; QTYPE that enables precision in HLA typing; and Ottr, a transplant patient management software. In addition, it provides AlloSeq Tx, a high-resolution HLA typing solution; AlloSeq cfDNA, a surveillance solution to measure dd-cfDNA in blood; AlloSeq HCT, a solution for chimerism testing for stem cell transplant recipients; Allocell, a surveillance solution that monitors the level of engraftment and persistence of allogeneic cells for patients who have received cell therapy transplants; and XynQAPI, a transplant quality tracking software, as well as AlloCare, a mobile app that offers a patient-centric resource for transplant recipients. The company offers its products directly to customers, as well as through third-party distributors and sub-distributors. It has a license agreement with Illumina, Inc. for the distribution, development, and commercialization of NGS products and technologies; and Cibiltech SAS to commercialize iBox, a software for the predictive analysis of post-transplantation kidney allograft loss. The company was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in March 2014. The company was incorporated in 1998 and is headquartered in South San Francisco, California.

Ações relacionadas

Twist Bioscience Corporation

TWST ▼1.06% | US$ 48,17

Personalis, Inc.

PSNL ▼0.39% | US$ 5,87

Veracyte, Inc.

VCYT ▼0.83% | US$ 40,12

Fate Therapeutics, Inc.

FATE ▼0.01% | US$ 1,61

Iovance Biotherapeutics, Inc.

IOVA ▼0.23% | US$ 7,37

Fique por dentro das últimas notícias do mundo financeiro em nosso Blog

Mantenha-se atualizado com as últimas notícias financeiras em nosso Blog. Publicamos artigos informativos e análises de especialistas para fornecer insights valiosos sobre o cenário financeiro em constante evolução.

Assine nossa newsletter para receber atualizações gratuitas por e-mail

Mantenha-se informado assinando nossa newsletter. Receba atualizações gratuitas por e-mail, incluindo rendimentos, novidades do mercado e insights valiosos. Estamos comprometidos em fornecer informações relevantes diretamente à sua caixa de entrada.

Conheça os Planos e Preços personalizados para acessar recursos exclusivos

Explore nossos Planos e Preços para obter acesso a recursos exclusivos, atendendo às suas necessidades específicas. Oferecemos opções flexíveis para investidores de todos os níveis, garantindo que você tenha as ferramentas certas para otimizar sua estratégia de investimento.